Statements (54)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
virus
|
| gptkbp:associated_with |
gptkb:myocarditis
pleurodynia viral meningitis |
| gptkbp:causedBy |
hand, foot, and mouth disease
|
| gptkbp:classification |
RNA virus
non-enveloped virus |
| gptkbp:clinicalTrials |
mild to moderate illness
self-limiting disease |
| gptkbp:community |
monitoring required
|
| gptkbp:community_outreach |
public awareness campaigns
contact tracing quarantine measures |
| gptkbp:complement |
no long-term immunity
temporary immunity after infection |
| gptkbp:complications |
dehydration
neurological issues cardiac issues |
| gptkbp:conflict |
Enterovirus
Echovirus |
| gptkbp:diseaseResistance |
clinical evaluation
global distribution laboratory tests occurs in feces occurs in respiratory secretions outbreaks reported |
| gptkbp:duration |
usually 7 to 10 days
|
| gptkbp:family |
Picornaviridae
|
| gptkbp:genus |
gptkb:Coxsackievirus
|
| gptkbp:healthcare |
monitor for complications
maintain hydration during illness seek medical attention if severe symptoms occur |
| https://www.w3.org/2000/01/rdf-schema#label |
Coxsackie
|
| gptkbp:impact |
pain relief medication
hydration therapy symptomatic care |
| gptkbp:is_available_in |
1948
|
| gptkbp:is_recognized_for |
Coxsackie, New York
|
| gptkbp:notable_player |
no specific vaccine available
|
| gptkbp:research |
ongoing studies
|
| gptkbp:riskManagement |
immunocompromised individuals
children under 5 |
| gptkbp:safetyFeatures |
good_hygiene_practices
|
| gptkbp:seasonalActivities |
more common in summer and fall
|
| gptkbp:surrounding_area |
skin
gastrointestinal tract respiratory tract mucous membranes |
| gptkbp:symptoms |
fever
sore throat rash mouth sores |
| gptkbp:transmission |
fecal-oral route
respiratory droplets |